FDA Inspection 1201080 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on March 24, 2023 in Anderson, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Anderson, IN (United States)